М. М. Петрова

2.5k total citations
166 papers, 1.1k citations indexed

About

М. М. Петрова is a scholar working on Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Neurology. According to data from OpenAlex, М. М. Петрова has authored 166 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Cardiology and Cardiovascular Medicine, 35 papers in Psychiatry and Mental health and 29 papers in Neurology. Recurrent topics in М. М. Петрова's work include Neurological Disorders and Treatments (23 papers), Healthcare Systems and Public Health (14 papers) and Cardiac Health and Mental Health (13 papers). М. М. Петрова is often cited by papers focused on Neurological Disorders and Treatments (23 papers), Healthcare Systems and Public Health (14 papers) and Cardiac Health and Mental Health (13 papers). М. М. Петрова collaborates with scholars based in Russia, Kazakhstan and United States. М. М. Петрова's co-authors include N. А. Shnayder, Р. Ф. Насырова, Tatiana N. Zamay, Е. Yu. Mozheyko, Maxim V. Berezovski, Galina S. Zamay, Olga S. Kolovskaya, Ana Gargaun, Anna S. Kichkailo and Mustafa Al-Zamil and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

М. М. Петрова

127 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
М. М. Петрова Russia 16 256 175 133 128 120 166 1.1k
Michael Brainin Austria 7 213 0.8× 171 1.0× 160 1.2× 81 0.6× 98 0.8× 11 1.2k
Chien‐Tai Hong Taiwan 22 305 1.2× 133 0.8× 183 1.4× 74 0.6× 49 0.4× 100 1.3k
Jin A Yoon South Korea 15 132 0.5× 79 0.5× 80 0.6× 74 0.6× 62 0.5× 80 727
Jung‐Sun Lee South Korea 21 413 1.6× 117 0.7× 72 0.5× 98 0.8× 125 1.0× 50 1.1k
So‐Young Jung South Korea 20 179 0.7× 101 0.6× 255 1.9× 68 0.5× 44 0.4× 78 1.6k
Vladimir N. Nikolenko Russia 19 368 1.4× 96 0.5× 139 1.0× 46 0.4× 28 0.2× 200 1.4k
Rie Yoshida Japan 22 480 1.9× 115 0.7× 136 1.0× 28 0.2× 157 1.3× 78 1.5k
Nastaran Rahimi Iran 20 260 1.0× 182 1.0× 206 1.5× 38 0.3× 40 0.3× 64 1.1k
Long Qian China 23 105 0.4× 64 0.4× 105 0.8× 56 0.4× 56 0.5× 95 1.3k

Countries citing papers authored by М. М. Петрова

Since Specialization
Citations

This map shows the geographic impact of М. М. Петрова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by М. М. Петрова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites М. М. Петрова more than expected).

Fields of papers citing papers by М. М. Петрова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by М. М. Петрова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by М. М. Петрова. The network helps show where М. М. Петрова may publish in the future.

Co-authorship network of co-authors of М. М. Петрова

This figure shows the co-authorship network connecting the top 25 collaborators of М. М. Петрова. A scholar is included among the top collaborators of М. М. Петрова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with М. М. Петрова. М. М. Петрова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shnayder, N. А., et al.. (2025). Selective serotonin reuptake inhibitors in pediatric neurology: a safety issue (systematic review). SHILAP Revista de lepidopterología. 19(4). 29–41.
2.
Shnayder, N. А., et al.. (2025). Circulating MicroRNAs Are Promising Biomarkers for Assessing the Risk of Antipsychotic-Induced Metabolic Syndrome (Review): Part 1. SHILAP Revista de lepidopterología. 13(3). 344–356.
3.
Насырова, Р. Ф., et al.. (2024). Antipsychotic-Induced QT Prolongation and Torsade de Pointes in Patients with Mental Disorders: A Review. SHILAP Revista de lepidopterología. 12(4). 380–395. 4 indexed citations
4.
Петрова, М. М., et al.. (2023). Roleofoxytocinin the protective function of the cardiovascular system. Complex Issues of Cardiovascular Diseases. 11(4). 130–138.
5.
6.
Shnayder, N. А., et al.. (2023). Valproate-Induced Metabolic Syndrome. Biomedicines. 11(5). 1499–1499. 11 indexed citations
7.
Shnayder, N. А., et al.. (2023). Therapeutic and Toxic Effects of Valproic Acid Metabolites. Metabolites. 13(1). 134–134. 43 indexed citations
8.
Насырова, Р. Ф., et al.. (2023). Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review. Genes. 14(3). 616–616. 2 indexed citations
9.
Петрова, М. М., et al.. (2022). Connective tissue disease in the practice of a cosmetologist and dermatologist. Features of diagnosis and management of patients. Vestnik dermatologii i venerologii. 98(1). 19–32. 2 indexed citations
10.
Shnayder, N. А., et al.. (2022). Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome. Metabolites. 12(8). 726–726. 14 indexed citations
11.
Shnayder, N. А., et al.. (2022). Regulation of elastin turnover in the skin: Biological and genetic aspects. Russian Journal of Clinical Dermatology and Venereology. 21(4). 435–435. 2 indexed citations
12.
Петрова, М. М., et al.. (2021). Pharmacokinetics and Pharmacogenetics of Dabigatran. SHILAP Revista de lepidopterología. 17(1). 146–152. 1 indexed citations
13.
Потекаев, Н. Н., et al.. (2021). Genetic and Epigenetic Aspects of Skin Collagen Fiber Turnover and Functioning. Cosmetics. 8(4). 92–92. 15 indexed citations
14.
Zyryanov, S. К., et al.. (2021). Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer. SHILAP Revista de lepidopterología. 14(3). 281–290. 2 indexed citations
15.
Shnayder, N. А., et al.. (2021). Candidate Genes and Proteomic Biomarkers of Serum and Urine in Medication-Overuse Headache. International Journal of Molecular Sciences. 22(16). 9024–9024. 1 indexed citations
16.
Петрова, М. М., et al.. (2021). Biomarkers and the prediction of adverse outcomes in patients with acute decompensated heart failure and kidney injury. Complex Issues of Cardiovascular Diseases. 10(3). 65–71. 1 indexed citations
17.
Zyryanov, S. К., et al.. (2020). Predicting Opioid Therapy Safety In Pancreatic Cancer Patients. SHILAP Revista de lepidopterología. 9(4).
18.
Shnayder, N. А., et al.. (2018). PHARMACOKINETIC AND PHARMACOGENETIC ASPECTS OF PERSONALIZED ANALGETIC THERAPY WITH FENTANIL TTS IN CLINICAL ONCOLOGY. Siberian Journal of Oncology. 17(3). 94–100.
19.
Zamay, Tatiana N., Galina S. Zamay, Olga S. Kolovskaya, et al.. (2017). Current and Prospective Protein Biomarkers of Lung Cancer. Cancers. 9(11). 155–155. 116 indexed citations
20.
Петрова, М. М., et al.. (2008). Cognitive dysfunction in arterial hypertension patients. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Brainin Breakdown of academic impact, for papers by Chien‐Tai Hong Breakdown of academic impact, for papers by Jin A Yoon Breakdown of academic impact, for papers by Jung‐Sun Lee Breakdown of academic impact, for papers by So‐Young Jung Breakdown of academic impact, for papers by Vladimir N. Nikolenko Breakdown of academic impact, for papers by Rie Yoshida Breakdown of academic impact, for papers by Nastaran Rahimi Breakdown of academic impact, for papers by Long Qian
Rankless by CCL
2026